Swinburne medical cannabis driving trial starts

Swinburne is leading a trial as part of the Victorian Government’s $4.9 million investment in developing an informed position on medicinal cannabis and drug driving.
In summary
- The Allan Labor Government’s closed-circuit trial to investigate whether individuals who use medicinal cannabis can drive safely has begun.
- The 18-month trial conducted by Swinburne will assist in understanding how THC in medicinal cannabis impacts driving performance.
- Minister for Roads and Road Safety Melissa Horne has announced the world first trial kicked off at METEC Driver Training in Bayswater.
The first drive has taken place on the Victoria Government’s closed-circuit trial to investigate whether individuals who use medicinal cannabis can drive safely.
Minister for Roads and Road Safety Melissa Horne has announced the world first trial kicked off at METEC Driver Training in Bayswater.
Backed by a $4.9 million investment by the Government – the 18-month trial conducted by Swinburne University of Technology, will assist in understanding how THC in medicinal cannabis impacts driving performance and how this translates into risk on the road – with a regional trial track set to also begin in Anglesea.
Lead Researcher of Swinburne's Drugs and Driving Research Unit Professor Luke Downey says, "We've made significant strides in the articulation of our research vehicles, which are specifically designed to assess driving performance in real-world conditions".
Researchers will review participants’ ability to manage distractions and assess their driving performance including steering, braking and speed control.
The drivers will also be closely monitored throughout the trial and strict protections will be in place to make sure people at the track keep safe.
A qualified driving instructor will be present in the vehicle at all phases of the driving assessments, with access to dual controls to intervene promptly if needed.
The private driving course mirrors real-world conditions and is away from public roads.
To qualify, participants must have been prescribed medicinal cannabis for a sleep disorder, chronic pain, or a mental health condition for at least six months. The trial will include pre and post-drive drug impairment screenings.
Minister for Roads and Road Safety Melissa Horne says, “In a world first trial, we have kicked off the first drive to gain a greater understanding on the effects of medicinal cannabis on driving in Victoria".
To learn more about the track trial, visit the trial website.
-
Media Enquiries
Related articles

- Health
World-first intravenous psychedelic trial to treat binge eating to launch
The world-first IV-administered psychedelic trial for binge eating disorder will kick off this year at Swinburne.

- Health
- Science
Swinburne to boost AI-driven design for dental devices with investment in H3D
Swinburne has invested in spinout company H3D, a cutting-edge tech company that is reinventing custom-fit devices using AI and automation.

- Health
- Science
Medical cannabis mysteries to be unlocked by new five-year NHMRC project
A new Swinburne-led medical cannabis investigation aims to help close the knowledge gap surrounding the drug and its potential in society.

- Health
- University
Swinburne educator excellence recognised in Australian Awards for University Teaching
Swinburne educators Dr Faith Kwa, Associate Professor Junhua Xiao, Dr Jessica Mackelprang and Dr James Williams were recognised for their teaching excellence in Health Sciences for thr 2024 Australian Awards for University Teaching.

- University
- Sustainability
Swinburne surges into top 300 in QS Sustainability Rankings 2025
Swinburne University of Technology has climbed to number 270 in the world in the QS Sustainability Ranking 2025.
-
- Health
World-first intravenous psychedelic trial to treat binge eating to launch
The world-first IV-administered psychedelic trial for binge eating disorder will kick off this year at Swinburne.
Thursday 10 April 2025 -
- Health
- Science
Swinburne to boost AI-driven design for dental devices with investment in H3D
Swinburne has invested in spinout company H3D, a cutting-edge tech company that is reinventing custom-fit devices using AI and automation.
Monday 31 March 2025 -
- Health
- Science
Medical cannabis mysteries to be unlocked by new five-year NHMRC project
A new Swinburne-led medical cannabis investigation aims to help close the knowledge gap surrounding the drug and its potential in society.
Wednesday 26 February 2025 -
- Health
- University
Swinburne educator excellence recognised in Australian Awards for University Teaching
Swinburne educators Dr Faith Kwa, Associate Professor Junhua Xiao, Dr Jessica Mackelprang and Dr James Williams were recognised for their teaching excellence in Health Sciences for thr 2024 Australian Awards for University Teaching.
Tuesday 25 February 2025 -
- University
- Sustainability
Swinburne surges into top 300 in QS Sustainability Rankings 2025
Swinburne University of Technology has climbed to number 270 in the world in the QS Sustainability Ranking 2025.
Wednesday 11 December 2024